The hypothesis being tested in this study is that hypofractionated radiotherapy of 55 Gy/16 fractions/4 weeks will be well tolerated with acute and late toxicity comparable to conventional radiotherapy. The secondary objective is to determine the rate of biochemical control and the need for complex treatment planning (IMRT) as opposed to 3D conformal therapy.